(R)-roscovitine, a cyclin-dependent kinase inhibitor, enhances tonic GABA inhibition in rat hippocampus

Neuroscience

Volumn 156, Issue 2, 2008, Pages 277-288

  Ivanov, A ^a   Tyzio, R ^a   Zilberter, Y ^a   Ben Ari, Yehezkel ^a  

^a Turing Center for Living Systems CENTURI Aix Marseille University   (France)

Author keywords

cyclin dependent protein kinase; GABA transport

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; CYCLIN DEPENDENT KINASE INHIBITOR; ROSCOVITINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GABAERGIC SYSTEM; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT;

6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ANIMALS; ANIMALS, NEWBORN; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; ELECTRIC STIMULATION; EXCITATORY AMINO ACID ANTAGONISTS; GABA AGENTS; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; HIPPOCAMPUS; INHIBITORY POSTSYNAPTIC POTENTIALS; MEMBRANE POTENTIALS; NEURAL INHIBITION; NEURONS; PATCH-CLAMP TECHNIQUES; PROTEIN KINASE INHIBITORS; PURINES; RATS;

EID: 52949089302     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.06.044     Document Type: Article

References (45)

1. Asada H., Kawamura Y., Maruyama K., Kume H., Ding R.G., Kanbara N., Kuzume H., Sanbo M., Yagi T., and Obata K. Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci U S A 94 12 (1997) 6496-6499
2. Bach S., Knockaert M., Reinhardt J., Lozach O., Schmitt S., Baratte B., Koken M., Coburn S.P., Tang L., Jiang T., Liang D.C., Galons H., Dierick J.F., Pinna L.A., Meggio F., Totzke F., Schachtele C., Lerman A.S., Carnero A., Wan Y., Gray N., and Meijer L. Roscovitine targets, protein kinases and pyridoxal kinase. J Biol Chem 280 35 (2005) 31208-31219
3. Bai D., Pennefather P.S., MacDonald J.F., and Orser B.A. The general anesthetic propofol slows deactivation and desensitization of GABA(A) receptors. J Neurosci 19 24 (1999) 10635-10646
4. Bai D., Zhu G., Pennefather P., Jackson M.F., MacDonald J.F., and Orser B.A. Distinct functional and pharmacological properties of tonic and quantal inhibitory postsynaptic currents mediated by gamma-aminobutyric acid(A) receptors in hippocampal neurons. Mol Pharmacol 59 4 (2001) 814-824
5. Buraei Z., Schofield G., and Elmslie K.S. Roscovitine differentially affects CaV2 and Kv channels by binding to the open state. Neuropharmacology 52 3 (2007) 883-894
6. Cammack J.N., Rakhilin S.V., and Schwartz E.A. GABA transporter operates asymmetrically and with variable stoichiometry. Neuron 13 4 (1994) 949-960
7. Christie S.B., Miralles C.P., and De Blas A.L. GABAergic innervation organizes synaptic and extrasynaptic GABAA receptor clustering in cultured hippocampal neurons. J Neurosci 22 3 (2002) 684-697
8. Conti F., Minelli A., and Melone M. GABA transporters in the mammalian cerebral cortex: localization, development and pathological implications. Brain Res Rev 45 3 (2004) 196-212
9. Eliot A.C., and Kirsch J.F. Pyridoxal phosphate enzymes: mechanistic, structural, and evolutionary considerations. Annu Rev Biochem 73 (2004) 383-415
10. Gaspary H.L., Wang W., and Richerson G.B. Carrier-mediated GABA release activates GABA receptors on hippocampal neurons. J Neurophysiol 80 1 (1998) 270-281
11. Glykys J., and Mody I. The main source of ambient GABA responsible for tonic inhibition in the mouse hippocampus. J Physiol 582 Pt 3 (2007) 1163-1178
12. Gram L., Larsson O.M., Johnsen A.H., and Schousboe A. Effects of valproate, vigabatrin and aminooxyacetic acid on release of endogenous and exogenous GABA from cultured neurons. Epilepsy Res 2 2 (1988) 87-95
13. Gruen R.J., Friedhoff A.J., Coale A., and Moghaddam B. Tonic inhibition of striatal dopamine transmission: effects of benzodiazepine and GABAA receptor antagonists on extracellular dopamine levels. Brain Res 599 1 (1992) 51-56
14. Isaacson J.S., Solis J.M., and Nicoll R.A. Local and diffuse synaptic actions of GABA in the hippocampus. Neuron 10 (1993) 165-175
15. Iseki H., Ko T.C., Xue X.Y., Seapan A., and Townsend Jr. C.M. A novel strategy for inhibiting growth of human pancreatic cancer cells by blocking cyclin-dependent kinase activity. J Gastrointest Surg 2 (1998) 36-43
16. Jolkkonen J., Mazurkiewicz M., Lahtinen H., and Riekkinen P. Acute effects of gamma-vinyl GABA on the GABAergic system in rats as studied by microdialysis. Eur J Pharmacol 229 2-3 (1992) 269-272
17. Kim D.W., Yoon C.S., Eum W.S., Lee B.R., An J.J., Lee S.H., Lee S.R., Ahn J.Y., Kwon O.S., Kang T.C., Won M.H., Cho S.W., Lee K.S., Park J., and Choi S.Y. Site-directed mutagenesis of human brain GABA transaminase: lysine-357 is involved in cofactor binding at the active site. Mol Cells 18 3 (2004) 314-319
18. Krapivinsky G., Krapivinsky L., Manasian Y., Ivanov A., Tyzio R., Pellegrino C., Ben-Ari Y., Clapham D.E., and Medina I. The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1. Neuron 40 4 (2003) 775-784
19. Lee H.R., Chang T.H., Tebalt III M.J., Senderowicz A.M., and Szabo E. Induction of differentiation accompanies inhibition of Cdk2 in a non-small cell lung cancer cell line. Int J Oncol 15 (1999) 161-166
20. Li B.S., Sun M.K., Zhang L., Takahashi S., Ma W., Vinade L., Kulkarni A.B., Brady R.O., and Pant H.C. Regulation of NMDA receptors by cyclin-dependent kinase-5. Proc Natl Acad Sci U S A 98 22 (2001) 12742-12747
21. Liu Q.Y., Schaffner A.E., Chang Y.H., Maric D., and Barker J.L. Persistent activation of GABA(A) receptor/Cl(-) channels by astrocyte-derived GABA in cultured embryonic rat hippocampal neurons. J Neurophysiol 84 3 (2000) 1392-1403
22. Mager S., Naeve J., Quick M., Labarca C., Davidson N., and Lester H.A. Steady states, charge movements, and rates for a cloned GABA transporter expressed in Xenopus oocytes. Neuron 10 2 (1993) 177-188
23. Meijer L., Borgne A., Mulner O., Chong J., Blow J., Inagaki N., Inagaki M., Delcros J., and Moulinoux J. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem 243 (1997) 527-536
24. Meijer L., and Raymond E. Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials. Acc Chem Res 36 6 (2003) 417-425
25. Mihara M., Shintani S., Kiyota A., Matsumura T., and Wong D.T. Cyclin-dependent kinase inhibitor (roscovitine) suppresses growth and induces apoptosis by regulating Bcl-x in head and neck squamous cell carcinoma cells. Int J Oncol 21 (2002) 95-101
26. Moor E., DeBoer P., and Westerink B.H. GABA receptors and benzodiazepine binding sites modulate hippocampal acetylcholine release in vivo. Eur J Pharmacol 359 2-3 (1998) 119-126
27. Nusser Z., and Mody I. Selective modulation of tonic and phasic inhibitions in dentate gyrus granule cells. J Neurophysiol 87 5 (2002) 2624-2628
28. Overstreet L.S., and Westbrook G.L. Paradoxical reduction of synaptic inhibition by vigabatrin. J Neurophysiol 86 2 (2001) 596-603
29. Ribak C.E., Tong W.M., and Brecha N.C. GABA plasma membrane transporters, GAT-1 and GAT-3, display different distributions in the rat hippocampus. J Comp Neurol 367 4 (1996) 595-606
30. Richerson G.B., and Wu Y. Dynamic equilibrium of neurotransmitter transporters: not just for reuptake anymore. J Neurophysiol 90 (2003) 1363-1374
31. Rossi D.J., and Hamann M. Spillover-mediated transmission at inhibitory synapses promoted by high affinity alpha6 subunit GABA(A) receptors and glomerular geometry. Neuron 20 4 (1998) 783-795
32. Scimemi A., Semyanov A., Sperk G., Kullmann D.M., and Walker M.C. Multiple and plastic receptors mediate tonic GABAA receptor currents in the hippocampus. J Neurosci 25 43 (2005) 10016-10024
33. Semyanov A., Walker M.C., and Kullmann D.M. GABA uptake regulates cortical excitability via cell type-specific tonic inhibition. Nat Neurosci 6 5 (2003) 484-490
34. Senderowicz A.M. Novel small molecule cyclin-dependent kinases modulators in human clinical trials. Cancer Biol Ther 2 (2003) S84-S95
35. Soltesz I., Smetters D.K., and Mody I. Tonic inhibition originates from synapses close to the soma. Neuron 14 6 (1995) 1273-1283
36. Tang L., Li M.H., Cao P., Wang F., Chang W.R., Bach S., Reinhardt J., Ferandin Y., Galons H., Wan Y., Gray N., Meijer L., Jiang T., and Liang D.C. Crystal structure of pyridoxal kinase in complex with roscovitine and derivatives. J Biol Chem 280 35 (2005) 31220-31229
37. - channels are randomly activated by continuous GABA secretion in cultured embryonic rat hippocampal neurons. Neurosci Lett 155 2 (1993) 199-203
38. Vautrin J., Maric D., Sukhareva M., Schaffner A.E., and Barker J.L. Surface-accessible GABA supports tonic and quantal synaptic transmission. Synapse 37 1 (2000) 38-55
39. Vita M., Abdel-Rehim M., Olofsson S., Hassan Z., Meurling L., Sidén A., Sidén M., Pettersson T., and Hassan M. Tissue distribution, pharmacokinetics and identification of roscovitine metabolites in rat. Eur J Pharm Sci 25 1 (2005) 91-103
40. Wu Y., Wang W., and Richerson G.B. Vigabatrin induces tonic inhibition via GABA transporter reversal without increasing vesicular GABA release. J Neurophysiol 89 (2003) 2021-2034
41. Wu Y., Wang W., and Richerson G.B. The transmembrane sodium gradient influences ambient GABA concentration by altering the equilibrium of GABA transporters. J Neurophysiol 96 5 (2006) 2425-2436
42. Wu Y., Wang W., Díez-Sampedro A., and Richerson G.B. Nonvesicular inhibitory neurotransmission via reversal of the GABA transporter GAT-1. Neuron 56 5 (2007) 851-865
43. Yan Z., Chi P., Bibb J.A., Ryan T.A., and Greengard P. Roscovitine: a novel regulator of P/Q-type calcium channels and transmitter release in central neurons. J Physiol 540 Pt 3 (2002) 761-770
44. Yeung J.Y., Canning K.J., Zhu G., Pennefather P., MacDonald J.F., and Orser B.A. Tonically activated GABAA receptors in hippocampal neurons are high-affinity, low-conductance sensors for extracellular GABA. Mol Pharmacol 63 1 (2003) 2-8
45. Zhang N., Wei W., Mody I., and Houser C.R. Altered localization of GABA(A) receptor subunits on dentate granule cell dendrites influences tonic and phasic inhibition in a mouse model of epilepsy. J Neurosci 27 28 (2007) 7520-7531